STDs and STIs are having a profound impact on sexual and reproductive health globally. Every year, there are an estimated 376 million new infections. Gonorrhoea, Chlamydia, Syphilis and Trichomoniasis are most commonly seen. HSV and HPV are the viruses causing these infections. These are causing the major death in women and newborns which need to be focused on. In 2017, global STD testing market was valued for $ 86,548.0 million. It is predicted to reach USD 133,935.7 million by 2025, at a CAGR of 5.6% from 2018- 2025. The diagnosis of these STDs caused by Syphilis is rising and is expected to account for over 20% of the market by 2022, growing at a CAGR over the forecast period due to high prevalence of syphilis infections globally.
Market Analysis: The Demyelinating Disorders market is experiencing varied Compound Annual Growth Rates (CAGRs) from 2025 to 2030, depending on the specific condition and market analysis. Projections for the overall Demyelinating Diseases Therapeutics Market range from 6.3% (2025-2034) to 10.7% (2024-2030). More specifically, the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market is expected to grow between 5.83% (reaching $3.50 billion by 2030 from $2.64 billion in 2025) and 7.50% (2025-2032). Furthermore, the Hereditary Central Nervous System Demyelinating Diseases Market is forecasted to see a 9.71% CAGR from 2025 to 2035.
